FDA Inspection
Martin Ekwealor Pharmaceuticals, Inc.Martin Ekwealor Pharmaceuticals, Inc. – FDA Inspection, Feb 17, 2010
Record Details
This FDA Inspection record concerns Martin Ekwealor Pharmaceuticals, Inc., with an inspection on February 17, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 17, 2010
- Product Type
- Drugs
View Company Profile
ID · a660f0a3-01dd-421d-89d3-39014f6d005c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 648367
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.80(a)Written Procedures Not Followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Martin Ekwealor Pharmaceuticals, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2016 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| July 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Martin Ekwealor Pharmaceuticals, Inc.
- FDA Inspection 1037070 - 2017-12-13
- FDA Inspection 963197 - 2016-03-24
- FDA Inspection 741026 - 2011-07-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.